Rutledge Ellis-Behnke

Dr. Rutledge Ellis-Behnke is a principle investigator in the Brain and Cognitive Sciences Department at Massachusetts Institute of Technology and the Department of Anatomy at the University of Hong Kong Li Ka Shing Faculty of Medicine. He is also Visiting Professor at Sichuan University in Chengdu, China. His primary interest is using nanobiotechnology to reconnect disconnected parts of the central nervous system (CNS).

He received his PhD in neuroscience from MIT, BS from Rutgers University and graduated from Harvard Business School’s International Senior Manager’s Program (AMP/ISMP).  Prior to returning to school to pursue his PhD, Dr. Ellis-Behnke held various management positions including senior vice president of a public company for testing and consulting services, and co-founder/CEO in 1995 of one of the first internet companies to do online commerce in computer memory.

 Dr. Ellis-Behnke is a Fellow and founding board member of the American Academy of Nanomedicine, Associate Editor of Neurology for the Journal of Nanomedicine, Scientific Advisory Board member for the Glaucoma Foundation, member of the New York Academy of Sciences, China Spinal Cord Injury Clinical Trial Network, Society for Neuroscience, Harvard Business School Health Industry Alumni Association and Sigma Xi. 

In addition to his work in neuroscience and nanomedicine he introduced the TabletPC to the classroom at MIT and the University of Hong Kong as part of the migration to the paperless classroom to deliver all course material and texts to the students digitally.